Novo Nordisk shares fell sharply after it said a pill with the key ingredient in Ozempic and Wegovy didn't slow Alzheimer's disease in two late-stage clinical trials
诺和诺德(US:NVO) WSJ·2025-11-24 20:39Oral semaglutide—the ingredient in obesity and diabetes drugs Ozempic and Wegovy—didn't slow Alzheimer's disease in two late-stage clinical trials. ...